<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD005517-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD005517-sec-0008"></div> <div class="table" id="CD005517-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span>Â <span class="table-title">MTA versus IRM for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>MTA versus IRM for retrograde filling in root canal therapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> UK and the Netherlands<br><b>Intervention:</b> MTA versus IRM </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of teeth<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>IRM</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>MTA</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome (tooth as unit of analysis)</b><br>Assessed by combination of clinical and radiological methods<br>Followâup: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>806 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>879 per 1000</b><br>(782 to 983) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.09</b><br>(0.97 to 1.22) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>222<br>(2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very</b><b>low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There may be little to no effect of MTA compared to IRM on success rate at 1 year but the evidence is very uncertain </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Outcome was not assessed by the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI) </p> <p><b>CI:</b> confidence interval; <b>IRM:</b> intermediate restorative material; <b>MTA:</b> mineral trioxide aggregate; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by 3 levels due to high risk of bias (downgraded by 1 level; both studies had the personnel unblinded due to the nature of the study design, andÂ <a href="./references#CD005517-bbs2-0001">Chong 2003</a>Â had incomplete outcome data reported) and imprecision (downgraded by 2 levels; small number of participants and wide confidence intervals including both benefit and no benefit).<br>Â  </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">MTA versus SuperâEBA for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>MTA versus SuperâEBA for retrograde filling in root canal therapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> South Korea<br><b>Intervention:</b> MTA versus SuperâEBA </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p>Number of <b>teeth</b><br>(studies) </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>SuperâEBA</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>MTA</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome (tooth as unit of analysis)</b><br>Assessed by combination of clinical and radiological methods<br>Followâup: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>931 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>959 per 1000</b><br>(894 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.03</b><br>(0.96 to 1.10) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>192<br>(1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There may be little to no effect of MTA compared to SuperâEBA on success rate at 1 year but the evidence is very uncertain </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Outcome was not assessed by the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI) </p> <p><b>CI:</b> confidence interval; <b>MTA:</b> mineral trioxide aggregate; <b>RR:</b> risk ratio; <b>SuperâEBA:</b> super ethoxybenzoic acid </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by 3 levels due to high risk of bias (downgraded by 1 level; the included study (<a href="./references#CD005517-bbs2-0004">Kim 2016</a>) had high risk of bias regarding incomplete data reporting and personnel blinding) and imprecision (downgraded by 2 levels; small population might cause serious imprecision). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span>Â <span class="table-title">SuperâEBA versus IRM for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>SuperâEBA versus IRM for retrograde filling in root canal therapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> Sweden<br><b>Intervention:</b> SuperâEBA versus IRM </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of teeth<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>IRM</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>SuperâEBA</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome (tooth as unit of analysis)</b><br>Assessed by combination of clinical and radiological methods<br>Followâup: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>906 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>815 per 1000</b><br>(725 to 915) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.90</b><br>(0.80 to 1.01) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>194<br>(1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence is very uncertain about the effect of SuperâEBA compared with IRM on success rate at 1 year, with results indicating SuperâEBA may reduce or have no effect on success rate </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Outcome was not assessed by the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI) </p> <p><b>CI:</b> confidence interval; <b>IRM:</b> intermediate restorative material; <b>RR:</b> risk ratio; <b>SuperâEBA:</b> super ethoxybenzoic acid </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by 3 levels due to high risk of bias (downgraded by 1 level; high risk of bias existed in the only included study (<a href="./references#CD005517-bbs2-0007">WÃ¤livaara 2011</a>) on allocation concealment and personnel blinding) and imprecision (downgraded by 2 levels; small number of participants and wide confidence intervals including both benefit and no benefit). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Dentineâbonded resin composite versus glass ionomer cement for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Dentineâbonded resin composite versus glass ionomer cement for retrograde filling in root canal therapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> Denmark<br><b>Intervention:</b> dentineâbonded resin composite versus glass ionomer cement </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of teeth/roots<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Glass ionomer cement</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Dentineâbonded resin composite</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome PP analysis (tooth as unit of analysis)</b><br>Assessed by combination of clinical and radiological methods<br>Followâup: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>306 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>731 per 1000</b><br>(490 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 2.39</b> <br>(1.60 to 3.59) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>122 teeth<br>(1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Compared to glass ionomer cement, dentineâbonded resin composite may increase the success rate of the treatment at 1 year but the evidence is very uncertain </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome PP analysis (root as unit of analysis)</b><br>Assessed by radiological methods<br>Followâup: mean 1 year </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>519 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>825 per 1000</b><br>(623 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.59</b><br>(1.20 to 2.09) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>127 roots<br>(1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Compared to glass ionomer cement, dentineâbonded resin composite may increase the success rate of the treatment at 1 year but the evidence is very uncertain </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Outcome was not assessed by the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>PP:</b> perâprotocol; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by 3 levels due to high risk of bias (downgraded by 1 level; the included study (<a href="./references#CD005517-bbs2-0002">Jensen 2002</a>) did not have participants, personnel, or outcome assessors blinded) and imprecision (downgraded by 2 levels; small population might cause serious imprecision). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Glass ionomer cement versus amalgam for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Glass ionomer cement versus amalgam for retrograde filling in root canal therapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> Sweden<br><b>Intervention:</b> glass ionomer cement versus amalgam </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of teeth<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Amalgam</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Glass ionomer cement</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome (tooth as unit of analysis)</b><br>Assessed by combination of clinical and radiological methods<br>Followâup: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>904 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>886 per 1000</b><br>(777 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.98</b> <br>(0.86 to 1.12) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>105<br>(1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The evidence is very uncertain about the effect of glass ionomer cement compared with amalgam on success rate at 1 year, with results indicating glass ionomer cement may reduce or have no effect on success rate </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Outcome was not assessed by the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI) </p> <p><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by 3 levels due to high risk of bias (downgraded by 1 level; the included study (<a href="./references#CD005517-bbs2-0003">Jesslen 1995</a>) had the personnel unblinded due to the nature of the study design) and imprecision (downgraded by 2 levels; small number of participants and wide confidence intervals including both benefit and no benefit). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0006"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 6.</span>Â <span class="table-title">MTA versus RRM for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>MTA versus RRM for retrograde filling in root canal therapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy </p> <p><b>Settings:</b> China </p> <p><b>Intervention:</b> MTA versus RRM </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of teeth<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>RRM</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>MTA</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate â 1âyear outcome (tooth as unit of analysis)</b> </p> <p>Assessed by combination of clinical and radiological methods</p> <p>Followâup: 1 year</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>933 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>896 per 1000</b><br>(840 to 970) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.00</b><br>(0.94 to 1.07) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>278<br>(2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There may be little to no effect of MTA compared to RRM on success rate at 1 year but the evidence is very uncertain </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Outcome was not assessed by the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup>The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI) </p> <p><b>CI:</b> confidence interval; <b>MTA:</b> mineral trioxide aggregate; <b>RR:</b> risk ratio; <b>RRM:</b> root repair material </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by 3 levels due to high risk of bias (downgraded by 1 level; the included studies (<a href="./references#CD005517-bbs2-0006">Safi 2019</a>;Â <a href="./references#CD005517-bbs2-0008">Zhou 2017</a>) had high risk of bias regarding personnel blinding) and imprecision (downgraded by 2 levels; small number of participants and wide confidence intervals including both benefit and no benefit). </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
